The study findings included a significantly lower 5-year disease-specific survival rate among those with amelanotic melanoma than among those with melanotic melanoma.

Melanoma symptoms provide key warning signs that can help you find this disease early, when it is most treatable. Learn ...

A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) ...

Like other cancers, melanoma is rising among young adults. It's now the 2nd most common cancer in 15 to 39 year-olds.

Medically reviewed by Marla Anderson, MD Diagnosing melanoma typically requires a physical exam and a biopsy. Imaging and ...

Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.

A new study uncovers how melanomas can arise from minimal genetic changes, shedding light on the early, often elusive steps ...

Researchers studied the progression-free and overall survival rates of patients with advanced melanoma after cessation of immune checkpoint inhibitor therapy.

Immunotherapy is effective in advanced melanoma, but not all patients respond, and its use in stage II melanoma remains controversial. 1 - 4 Clinically reliable biomarkers for therapeutic selection, ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

CHICAGO — Adults with unresectable stage III or IV melanoma maintained similar progression-free disease control with 1- or 2-year durations of immunotherapy, researchers reported at the American ...